CURRAX PHARMACEUTICALS LLC
Live / Registered — Registered (as of 26 Jul 2022)
What this means for you
Registered since 26 Jul 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88404065
- Registration number
- 6804470
- Mark type
- Design + words
- Filed
- 26 Apr 2019
- Published for opposition
- 16 Jul 2019
- Registered
- 26 Jul 2022
- Attorney of record
- Andrew N. Spivak
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in connection with humans for treatment of disorders, diseases and conditions of the endocrinology, cardiology, neurology, gastroenterology, pulmonary, and immune systems and for treatment of metabolic and psychiatric disorders, diseases and conditions
Owner
- Currax Pharmaceuticals LLC, Brentwood, TN, US
- Currax Pharmaceuticals LLC, Brentwood, TN, US
- Currax Pharmaceuticals LLC, Morristown, NJ, US
Prosecution history
- 26 Jul 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 26 Jul 2022 — REGISTERED-PRINCIPAL REGISTER
- 21 Jun 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Jun 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Jun 2022 — EXAMINER'S AMENDMENT ENTERED
- 15 Jun 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 15 Jun 2022 — EXAMINERS AMENDMENT E-MAILED
- 15 Jun 2022 — SU-EXAMINER'S AMENDMENT WRITTEN
- 24 May 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 May 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 May 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 18 May 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 May 2022 — NON-FINAL ACTION E-MAILED
- 18 May 2022 — SU - NON-FINAL ACTION - WRITTEN
- 19 Apr 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED